Fathers

3

Review clinical trials related to Fathers. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Regional Partnership to Improve Outcomes Through Fatherhood Engagement

Montefiore will engage fathers in families at risk of substance misuse in the Bronx and neighboring communities. Families will be referred from Bronx and neighboring community-based child welfare systems, substance use disorder (SUD) treatment providers, and medical providers if identified at risk of substance use concerns and will be randomly assigned to receive services as usual as part of the comparison group, or to receive enhanced services as part of the program group. Enhanced services include: (1) Motivational Enhancement; (2) referral to Healthy, Empowered, Resilient, and Open (HERO) Dads fatherhood engagement program; (3) Contingency Management; and (4) Case Management.

Participants needed: 240
Trial details
Age: 18+Biological sex: MaleType: InterventionalSponsor: Montefiore Medical CenterUpdated: Mar 24, 2026Locations: 1
Eligibility criteria

is a custodial or non-custodial father [+3]

The placement of all children in the family in foster care

Status: Recruiting

text4FATHER R21: Social Media - Efficacy Trial

This project will be the first to examine the efficacy of a text messaging intervention designed to recruit first-time fathers-to-be using social media across the U.S. to become involved during pregnancy through two months of postnatal age to support infant, mother, and father well-being.

Participants needed: 180
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Johns Hopkins UniversityUpdated: Sep 18, 2025Locations: 1
Eligibility criteria

Aged ≥18 years [+5]

Individuals who are minors [+5]

Status: Recruiting

Validation of the French Version of the Perinatal Assessment of Paternal Affectivity (PAPA)

The transition to parenthood is a critical period for both the woman and her partner, and this can affect the mental health of the parents. Like mothers, fathers are at risk of stress, anxiety, depression and post-traumatic stress disorder during the perinatal period. Existing screening or diagnostic tools have been developed on the basis of traditional depressive symptoms expressed by women. However, the manifestations of perinatal mental disorders appear to be different in men. It is therefore essential to develop tools that are sensitive and specific to both gender and the perinatal period in order to increase the sensitivity and specificity of screening for fathers. In France, to the best of the knowledge of the investigators, there is no validated tool in French to assess paternal psychological disorders, either prenatally or postnatally. Baldoni et al. had validated a brief self-report questionnaire, the " Perinatal Assessment of Paternal Affectivity " (PAPA), to screen for perinatal signs and symptoms of paternal affective disorder, using a gender-sensitive approach. The aim of this study is to cross-cultural adapt the PAPA in French and to evaluate its psychometric properties. This validation of the French-PAPA would provide a simple tool, easy to use in everyday practice, to detect any signs or symptoms of paternal psychopathological distress in the pre- and postnatal period.

Participants needed: 340
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University Hospital, Clermont-FerrandUpdated: Aug 14, 2025Locations: 1
Eligibility criteria

Woman and its male partner aged 18 years old and older [+2]

Woman without male partner [+7]